Investor Update

Basel, 20 May 2011

Roche ASCO Planner

Roche (SIX: RO, ROG; OTCQX: RHHBY) and Genentech will present a large number of abstracts on their broad oncology portfolio at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago on June 3 - 7, 2011.  In order to assist you, we have prepared an ASCO planner providing an overview of oral and poster abstracts relevant to us, including indication of time and venue of the presentation. This planner can be downloaded from our website via http://www.roche.com/asco_plan_2011.pdf

We will have a significant presence at the congress with almost 300 scientific abstracts submitted.

A summary of the key data presented at ASCO will be provided at the Analyst briefing on Sunday, June 5, 2011 in Chicago, which we invite you to attend. Details can be found on: http://www.roche.com/investors/ir_update/inv-update-2011-05-05.htm